Literature DB >> 10798364

Parental origin of the extra chromosome in prenatally diagnosed fetal trisomy 21.

F Muller1, M Rebiffé, A Taillandier, J F Oury, E Mornet.   

Abstract

Trisomy 21 (Down syndrome) is one of the most common chromosomal abnormalities. Of cases of free trisomy 21 causing Down syndrome, about 95% result from nondisjunction during meiosis, and about 5% are due to mitotic errors in somatic cells. Previous studies using DNA polymorphisms of chromosome 21 showed that paternal origin of trisomy 21 occurred in only 6.7% of cases. However, these studies were conducted in liveborn trisomy 21-affected infants, and the possible impact of fetal death was not taken into account. Using nine distinct DNA polymorphisms, we tested 110 families with a prenatally diagnosed trisomy 21 fetus. Of the 102 informative cases, parental origin was maternal in 91 cases (89.2%) and paternal in 11 (10.8%). This percentage differs significantly from the 7.0% observed in previous studies (P<0.001). In order to test the influence of genomic parental imprinting, we determined the origin of the extra chromosome 21 in relation to different factors: advanced maternal age, maternal serum human chorionic gonadotropin (hormone of placental origin), severity of the disease, gestational age at diagnosis and fetal gender. We found that the increased frequency of paternal origin of nondisjunction in trisomy 21-affected fetuses cannot obviously be explained by factors leading to selective loss of paternal origin fetuses.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10798364     DOI: 10.1007/s004390051047

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  6 in total

1.  Trisomy-21 gene dosage over-expression of miRNAs results in the haploinsufficiency of specific target proteins.

Authors:  Terry S Elton; Sarah E Sansom; Mickey M Martin
Journal:  RNA Biol       Date:  2010-09-01       Impact factor: 4.652

2.  Evidence for dysregulation of genome-wide recombination in oocytes with nondisjoined chromosomes 21.

Authors:  Candace D Middlebrooks; Nandita Mukhopadhyay; Stuart W Tinker; Emily Graves Allen; Lora J H Bean; Ferdouse Begum; Reshmi Chowdhury; Vivian Cheung; Kimberly Doheny; Marcia Adams; Eleanor Feingold; Stephanie L Sherman
Journal:  Hum Mol Genet       Date:  2013-09-06       Impact factor: 6.150

3.  Maternal age and risk for trisomy 21 assessed by the origin of chromosome nondisjunction: a report from the Atlanta and National Down Syndrome Projects.

Authors:  Emily Graves Allen; Sallie B Freeman; Charlotte Druschel; Charlotte A Hobbs; Leslie A O'Leary; Paul A Romitti; Marjorie H Royle; Claudine P Torfs; Stephanie L Sherman
Journal:  Hum Genet       Date:  2008-12-03       Impact factor: 4.132

4.  Effects of childhood and middle-adulthood family conditions on later-life mortality: evidence from the Utah Population Database, 1850-2002.

Authors:  Ken R Smith; Geraldine P Mineau; Gilda Garibotti; Richard Kerber
Journal:  Soc Sci Med       Date:  2009-03-09       Impact factor: 4.634

5.  Possible risk factors for Down syndrome and sex chromosomal aneuploidy in Mysore, South India.

Authors:  Suttur S Malini; Nallur B Ramachandra
Journal:  Indian J Hum Genet       Date:  2007-09

6.  The association of low socioeconomic status and the risk of having a child with Down syndrome: a report from the National Down Syndrome Project.

Authors:  Jessica Ezzell Hunter; Emily Graves Allen; Mikyong Shin; Lora J H Bean; Adolfo Correa; Charlotte Druschel; Charlotte A Hobbs; Leslie A O'Leary; Paul A Romitti; Marjorie H Royle; Claudine P Torfs; Sallie B Freeman; Stephanie L Sherman
Journal:  Genet Med       Date:  2013-04-04       Impact factor: 8.822

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.